Investing in Uranium ETFs: 9 Options for Uranium Exposure
Exchange-traded funds (ETFs) are one of the fastest-growing investment vehicles, and as uranium’s role in the energy transition grows, investors...
Triumph Gold Updates Shareholders on Operations, Engages Market Maker, and Grants Options
Reviews 2025 exploration strategy across Freegold Mountain and Andalusite Peak Advances acquisition strategy targeting high-grade silver assets Engages Independent Trading...
Buffett Hands Over Reins, What’s Next for Berkshire’s Capital Strategy?
Legendary investor Warren Buffett is stepping down as CEO of Berkshire Hathaway (NYSE:BRK.A,NYSE:BRK.B) after six decades at the helm —...
Cargo thieves are attacking the U.S. supply chain at alarming rates
America’s supply chain is under attack. From coast to coast, organized criminal groups are hitting trucks on the road, breaking...
Fed Watch: Key Bullish Patterns in the S&P 500, Utilities, and Crypto
The S&P 500 ($SPX) wrapped up Tuesday just below its intraday midpoint and posted one of the narrowest ranges we’ve...
Don’t Buy Robinhood Stock… Until You See This Chart Setup
Robinhood Markets, Inc. (HOOD) is back in the spotlight, wrestling with its four-year highs and turning heads on Wall Street....
Drill Contract Awarded for Elizabeth Hill. Technical Visit Completed to Define Drill Targets
Errawarra Resources Ltd (ASX: ERW) is pleased to advise that it has awarded its inaugural drilling contract at the high-grade...
Brunswick Exploration Announces Brokered Private Placement for Gross Proceeds of up to C$2.5 Million, with a Lead Order from a Strategic Investor
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Brunswick Exploration Inc....
$2.6M Placement and SPP to fast-track China entry and sales
Wide Open Agriculture (WOA:AU) has announced $2.6M Placement and SPP to fast-track China entry and sales Download the PDF here....
US Policy Momentum, Clinical Progress Fueling Psychedelics Market in 2025
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the...
